







To find out why GuruFocus thinks data on insider trade are interesting, read
| Symbol | Company | Insider | Position | Date | Buy/Sell | Shares | Trade Price ($) | Cost ($1000) | Price Change Since Trade (%) |
Yield (%) | P/E | Market Cap ($M) | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() | PGNX | Progenics Pharm... | Baker Mark Robert | CEO (Click for the stocks that their CEOs have bought) | 2013-02-27 | Buy | 1,262 | $2.72 | 3.4 | 49.26 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | Baker Mark Robert | CEO | 2013-01-22 | Buy | 1,215 | $2.82 | 3.4 | 43.97 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | Baker Mark Robert | CEO | 2012-12-26 | Buy | 1,142 | $3.01 | 3.4 | 34.88 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | Baker Mark Robert | CEO | 2012-11-28 | Buy | 1,607 | $2.13 | 3.4 | 90.61 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | Baker Mark Robert | CEO | 2012-11-19 | Buy | 11,800 | $1.96 | 23.1 | 107.14 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | Baker Mark Robert | CEO | 2012-11-16 | Buy | 49,793 | $1.82 | 90.6 | 123.08 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | Baker Mark Robert | CEO | 2012-11-15 | Buy | 48,833 | $1.69 | 82.5 | 140.24 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | Baker Mark Robert | CEO | 2012-10-24 | Buy | 1,162 | $2.96 | 3.4 | 37.16 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | Baker Mark Robert | CEO | 2012-09-26 | Buy | 1,036 | $3.32 | 3.4 | 22.29 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | ISRAEL ROBERT J | Senior VP Medical Affairs | 2012-07-02 | Sell | 1,000 | $9.79 | 9.8 | -58.53 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | ISRAEL ROBERT J | Senior VP Medical Affairs | 2012-06-01 | Sell | 1,000 | $8.51 | 8.5 | -52.29 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | ISRAEL ROBERT J | Senior VP Medical Affairs | 2012-05-01 | Sell | 1,000 | $10.93 | 10.9 | -62.85 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | ISRAEL ROBERT J | Senior VP Medical Affairs | 2012-04-02 | Sell | 1,000 | $9.85 | 9.9 | -58.78 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | ISRAEL ROBERT J | Senior VP Medical Affairs | 2012-03-01 | Sell | 1,000 | $9.82 | 9.8 | -58.66 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | SCHEINBERG DAVID A | Director | 2012-02-23 | Sell | 1,250 | $10 | 12.5 | -59.4 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | BRINER KURT W | Director | 2012-02-03 | Sell | 33,000 | $10.22 | 337.3 | -60.27 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | ISRAEL ROBERT J | Senior VP Medical Affairs | 2012-02-01 | Sell | 1,000 | $9.48 | 9.5 | -57.17 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | ISRAEL ROBERT J | Senior VP Medical Affairs | 2012-01-03 | Sell | 1,000 | $8.78 | 8.8 | -53.76 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | ISRAEL ROBERT J | Senior VP Medical Affairs | 2011-12-01 | Sell | 1,000 | $6.66 | 6.7 | -39.04 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | ISRAEL ROBERT J | Senior VP Medical Affairs | 2011-11-01 | Sell | 1,000 | $6.33 | 6.3 | -35.86 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | ISRAEL ROBERT J | Senior VP Medical Affairs | 2011-10-05 | Sell | 1,000 | $6.33 | 6.3 | -35.86 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | ISRAEL ROBERT J | Senior VP Medical Affairs | 2011-08-11 | Sell | 1,000 | $6.33 | 6.3 | -35.86 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | ISRAEL ROBERT J | Senior VP Medical Affairs | 2011-07-01 | Sell | 1,000 | $7.21 | 7.2 | -43.69 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | Olson William C | Senior VP, Research and Develo | 2011-06-21 | Sell | 2,872 | $7.09 | 20.4 | -42.74 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | ISRAEL ROBERT J | Senior VP Medical Affairs | 2011-06-21 | Sell | 7,889 | $7.02 | 55.4 | -42.17 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | MCKINNEY ROBERT A | Senior VP, CFO | 2011-06-17 | Sell | 3,000 | $7.5 | 22.5 | -45.87 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | ISRAEL ROBERT J | Senior VP Medical Affairs | 2011-06-01 | Sell | 1,000 | $8.15 | 8.2 | -50.18 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | BRINER KURT W | Director | 2011-05-16 | Sell | 20,000 | $8.24 | 164.8 | -50.73 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | ISRAEL ROBERT J | Sr. VP, Medical Affairs | 2011-05-02 | Sell | 1,000 | $7.39 | 7.4 | -45.06 | 0.00 | 0.00 | 199.562 | |
![]() | PGNX | Progenics Pharm... | ISRAEL ROBERT J | Sr. VP, Medical Affairs | 2011-04-01 | Sell | 1,000 | $6.33 | 6.3 | -35.86 | 0.00 | 0.00 | 199.562 |
| Guru Name | Portfolio Date* | Current Shares (?) | % of Total Assets (?) | Change from Last Holdings (?) | |
|---|---|---|---|---|---|
| Paul Tudor Jones | 2013-03-31 | 2,342,388 | 0.95% | ||
| Murray Stahl | 2013-03-31 | 65,200 | 0.01% | ||
| Jim Simons | 2013-03-31 | 0 | 0% | Sold Out | |
Most recent portfolio changes are included for Premium Members only!
| |||||
Add Notes, Comments or Ask Questions
Comments